Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

HARDBACK price:$42.95 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Modern Methods of Clinical Investigation The Development of Medications for the Treatment of Opiate and Cocaine Addictions:Issues for the Government and Private Sector Other Related Titles Marijuana and Medicine: Assessing the Science Base (1999) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix C Scheduling Definitions." Marijuana and Medicine: Assessing the Science Base. Washington, DC: The National Academies Press, 1999. Please select a format: Page 240   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Page 240 Appendix C Scheduling Definitions Scheduling Definitions Established By the Controlled Substances Act of 1970 Schedule I (includes heroin, LSD, and marijuana) (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has no currently accepted medical use in treatment in the United States. (C) There is a lack of accepted safety for the use of the drug or other substance under medical supervision. Schedule II (includes Marinol, methadone, morphine, methamphetamine, and cocaine) (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. (C) Abuse of the drug or other substances may lead to severe psychological or physical dependence. Schedule III (includes anabolic steroids) (A) The drug or other substance has a potential of abuse less than the drugs or other substances in Schedules I and II. Page 240 Front Matter (R1-R18) Executive Summary (1-12) 1 Introduction (13-32) 2 Cannabinoids and Animal Physiology (33-82) 3 First, Do No Harm: Consequences of Marijuana Use and Abuse (83-136) 4 The Medical Value of Marijuana and Related Substances (137-192) 5 Development of Cannabinoid Drugs (193-222) Appendix A Individuals and Organizations That Spoke or Wrote to the Institute of Medicine About Marijuana and Medicine (223-231) Appendix B Workshop Agendas (232-239) Appendix C Scheduling Definitions (240-241) Appendix D Statement of Task (242-243) Appendix E Recommendations Made in Recent Reports on the Medical Use of Marijuana (244-255) Appendix F Rescheduling Criteria (256-258) Index (259-267)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 240
Page 240 Appendix C Scheduling Definitions Scheduling Definitions Established By the Controlled Substances Act of 1970 Schedule I (includes heroin, LSD, and marijuana) (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has no currently accepted medical use in treatment in the United States. (C) There is a lack of accepted safety for the use of the drug or other substance under medical supervision. Schedule II (includes Marinol, methadone, morphine, methamphetamine, and cocaine) (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. (C) Abuse of the drug or other substances may lead to severe psychological or physical dependence. Schedule III (includes anabolic steroids) (A) The drug or other substance has a potential of abuse less than the drugs or other substances in Schedules I and II.

OCR for page 241
Page 241 (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence. Schedule IV (includes Valium and other tranquilizers) (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule III. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule III. Schedule V (includes codeine-containing analgesics) (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule IV. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule IV. SOURCES: LeCraw (1996) and 21 U.S.C. 812.

Representative terms from entire chapter:

accepted medical